Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Kyle

Showing results (11-20 of 887) with videos related to

Pageof 89
Sort By:
Clinical Chemistry|November 1, 1994
The monoclonal gammopathiesR A Kyle
Bailliere'S Clinical Haematology|June 1, 1987
Monoclonal gammopathy and multiple myeloma in the elderlyR A Kyle
Seminars in Hematology|April 20, 2001
Multiple Myeloma. Diagnostic challenges and standard therapyR A Kyle
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Multiple myeloma. An update on diagnosis and managementR A Kyle
Forum on Medicine|October 9, 1979
Blood transfusion and stampsR A Kyle
Scandinavian Journal of Haematology|July 1, 1985
Multiple myeloma: current therapy and a glimpse of the futureR A Kyle
The New England Journal of Medicine|February 10, 1983
Long-term survival in multiple myelomaR A Kyle
Stem Cells (Dayton, Ohio)|August 1, 1995
Prognostic factors in multiple myelomaR A Kyle
The New England Journal of Medicine|April 17, 1980
Natural history of chronic idiopathic neutropeniaR A Kyle
Hematology/Oncology Clinics of North America|February 1, 1997
Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myelomaR A Kyle
Pageof 89

Showing results (11-20 of 887) with videos related to

Sort By:
Pageof 89
Clinical Chemistry|November 1, 1994
The monoclonal gammopathiesR A Kyle
Bailliere'S Clinical Haematology|June 1, 1987
Monoclonal gammopathy and multiple myeloma in the elderlyR A Kyle
Seminars in Hematology|April 20, 2001
Multiple Myeloma. Diagnostic challenges and standard therapyR A Kyle
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Multiple myeloma. An update on diagnosis and managementR A Kyle
Forum on Medicine|October 9, 1979
Blood transfusion and stampsR A Kyle
Scandinavian Journal of Haematology|July 1, 1985
Multiple myeloma: current therapy and a glimpse of the futureR A Kyle
The New England Journal of Medicine|February 10, 1983
Long-term survival in multiple myelomaR A Kyle
Stem Cells (Dayton, Ohio)|August 1, 1995
Prognostic factors in multiple myelomaR A Kyle
The New England Journal of Medicine|April 17, 1980
Natural history of chronic idiopathic neutropeniaR A Kyle
Hematology/Oncology Clinics of North America|February 1, 1997
Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myelomaR A Kyle
Pageof 89